Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rinaldi

Showing results (151-160 of 175) with videos related to

Pageof 18
Sort By:
JACC. Cardiovascular Interventions|August 7, 2017
Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry StudyThomas D Stuckey, Ajay J Kirtane, Bruce R Brodie, et al.
The American Journal of Cardiology|December 8, 2015
Impact of Hemoglobin A1c Levels on Residual Platelet Reactivity and Outcomes After Insertion of Coronary Drug-Eluting Stents (from the ADAPT-DES Study)Mikkel M Schoos, George D Dangas, Roxana Mehran, et al.
International Journal of Cardiology|January 2, 2017
Two-year outcomes after percutaneous coronary intervention of calcified lesions with drug-eluting stentsPhilippe Généreux, Björn Redfors, Bernhard Witzenbichler, et al.
Journal of the American Heart Association|December 24, 2022
On-Treatment Platelet Reactivity and Ischemic Outcomes in Patients With Diabetes Mellitus: Two-Year Results From ADAPT-DESBahira Shahim, Björn Redfors, Thomas D Stuckey, et al.
American Heart Journal|March 22, 2019
Adverse events in patients with high platelet reactivity following successful chronic total occlusion PCI: The Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents (ADAPT-DES) studyMatthew T Finn, Björn Redfors, Dimitri Karmpaliotis, et al.
The American Journal of Cardiology|April 13, 2016
Relation Between Platelet Count and Platelet Reactivity to Thrombotic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents StudyGennaro Giustino, Ajay J Kirtane, Philippe Généreux, et al.
Nature|December 7, 2021
Long-acting capsid inhibitor protects macaques from repeat SHIV challengesSamuel J Vidal, Elena Bekerman, Derek Hansen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 16, 2021
Outcomes of transcatheter mitral valve repair for secondary mitral regurgitation by severity of left ventricular dysfunctionStamatios Lerakis, Annapoorna S Kini, Federico M Asch, et al.
The American Journal of Cardiology|May 2, 2016
Impact of Anemia on Platelet Reactivity and Ischemic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents StudyGennaro Giustino, Ajay J Kirtane, Usman Baber, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 14, 2019
Impact of high on-treatment platelet reactivity on outcomes following PCI in patients on hemodialysis: An ADAPT-DES substudyGeoffrey A Rubin, Ajay J Kirtane, Shmuel Chen, et al.
Pageof 18

Showing results (151-160 of 175) with videos related to

Sort By:
Pageof 18
JACC. Cardiovascular Interventions|August 7, 2017
Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry StudyThomas D Stuckey, Ajay J Kirtane, Bruce R Brodie, et al.
The American Journal of Cardiology|December 8, 2015
Impact of Hemoglobin A1c Levels on Residual Platelet Reactivity and Outcomes After Insertion of Coronary Drug-Eluting Stents (from the ADAPT-DES Study)Mikkel M Schoos, George D Dangas, Roxana Mehran, et al.
International Journal of Cardiology|January 2, 2017
Two-year outcomes after percutaneous coronary intervention of calcified lesions with drug-eluting stentsPhilippe Généreux, Björn Redfors, Bernhard Witzenbichler, et al.
Journal of the American Heart Association|December 24, 2022
On-Treatment Platelet Reactivity and Ischemic Outcomes in Patients With Diabetes Mellitus: Two-Year Results From ADAPT-DESBahira Shahim, Björn Redfors, Thomas D Stuckey, et al.
American Heart Journal|March 22, 2019
Adverse events in patients with high platelet reactivity following successful chronic total occlusion PCI: The Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents (ADAPT-DES) studyMatthew T Finn, Björn Redfors, Dimitri Karmpaliotis, et al.
The American Journal of Cardiology|April 13, 2016
Relation Between Platelet Count and Platelet Reactivity to Thrombotic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents StudyGennaro Giustino, Ajay J Kirtane, Philippe Généreux, et al.
Nature|December 7, 2021
Long-acting capsid inhibitor protects macaques from repeat SHIV challengesSamuel J Vidal, Elena Bekerman, Derek Hansen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 16, 2021
Outcomes of transcatheter mitral valve repair for secondary mitral regurgitation by severity of left ventricular dysfunctionStamatios Lerakis, Annapoorna S Kini, Federico M Asch, et al.
The American Journal of Cardiology|May 2, 2016
Impact of Anemia on Platelet Reactivity and Ischemic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents StudyGennaro Giustino, Ajay J Kirtane, Usman Baber, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 14, 2019
Impact of high on-treatment platelet reactivity on outcomes following PCI in patients on hemodialysis: An ADAPT-DES substudyGeoffrey A Rubin, Ajay J Kirtane, Shmuel Chen, et al.
Pageof 18